NIH-funded research R01 grant

Protecting children with transplants from respiratory viruses

Official title: Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients

Funded at Arkansas Children's Hospital Res Inst · NIH-11176081 · Data updated 2026-11-12

This project follows children having organ or stem-cell transplants to track viruses and immune responses so doctors can better predict and prevent serious lung infections.

More Transplant research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionArkansas Children's Hospital Res Inst
NIH-funded
Lab location1 site (Little Rock, United States)
Project startSeptember 17, 2021
Project endAugust 31, 2027
Funding year2025
Award (this year)$1,502,393
NIH project number4R01AI159684-06
Project IDNIH-11176081 on NIH RePORTER

Who could benefit from this research

Could help

Children aged 0–11 who are planning to have or recently had a hematopoietic cell (bone marrow/stem cell) transplant or a solid organ transplant and whose caregivers agree to provide blood and nasal samples.

Less likely to help

This project is not designed for adults, older teens, or children who are not transplant recipients, so they are unlikely to benefit directly.

What this research studies

You would be part of a group of 2,000 children treated across a nationwide network of pediatric transplant centers. Doctors will collect blood and nasal samples before transplant and during follow-up, measure viral amounts, read virus genetic sequences, and study immune responses like antibodies and T cells. A smaller nested comparison will look closely at children who develop severe lung disease versus those who do not to find patterns that predict risk. The information will be used to build tools to help families and clinicians make safer transplant and treatment decisions.

Why it matters

Potential benefit: If successful, this work could help identify children at high risk for severe lung infections so care can be personalized and complications reduced.

How similar studies have gone: Smaller prior studies suggest viral load and immune markers relate to severity, but this large multi-center effort combining sequencing and immune testing is a novel and broader approach.

Where this research is happening

  • Arkansas Children's Hospital Res Inst
    Little Rock, United States
    Active

Researchers

  • Principal investigator: Steinbach, William J — Arkansas Children's Hospital Res Inst
  • Study coordinator: Steinbach, William J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.